Low Dose Naltrexone (LDN) is a drug that may help regulate a dysfunctional immune system in autoimmune diseases such as Cancers, HIV/Aids, Fibromyalgia, MS, Crohn's etc. LDN can be prescribed "off-label" on the NHS and has few side effects. We strive to make LDN a first line treatment available for all on the NHS.

Bookmark and Share
My Charity Page Start Fundraising
Newsletter Signup

Email:


Enter the numbers
into box below



MP3's

Please find below MP3's that can be downloaded.

WORLD CONGRESS ON ANTIAGING MEDICINE AND REGENERATIVE AND BIOMEDICAL TECHNOLOGIES, LAS VEGAS, 12 DECEMBER 2009

(www.worldhealth.net)

LDN PRESENTATION - AUDIO RECORDING:

'Low Dose Naltrexone and its Regulatory Effects on Cancer Cell Growth and Autoimmune Disease'

Sub-Topics:

(a) The Endorphin and Metenkephalin physiology in immune function

(b) Effects of Low Dose Naltrexone and Opiate Growth Factor in changing the immune response.

(c) Clinical studies and appropriate clinical applications that LDN has been used for.

(d) How patients use LDN.

PRESENTER:

Paul Battle, PA-C (Physician Assistant), Broomfield, Colorado

POST CONFERENCE SUMMARY:

Attendance numbers were larger than anticipated - 4000 physicians attended the conference. The LDN topic was 'highly rated' so a larger lecture room was allocated for attendees, accommodating approx 150 physicians. The moderator for the afternoon was himself a prescriber of LDN. Terry Grossman (who spoke at the LDN conference in 2007) attended the lecture and said it went well. Paul will have a 10-20 page chapter in the post-conference book. The Antiaging Medicine Organization will publish and distribute the book to around 100 different countries in medical centers and libraries.

Click here to download MP3.

Hosted by LWR Online : Surveys Powered by Fluid Surveys
Business Cards and Printing Services provided by CardsMadeEasy